CN110526940A - 一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 - Google Patents
一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 Download PDFInfo
- Publication number
- CN110526940A CN110526940A CN201910762744.XA CN201910762744A CN110526940A CN 110526940 A CN110526940 A CN 110526940A CN 201910762744 A CN201910762744 A CN 201910762744A CN 110526940 A CN110526940 A CN 110526940A
- Authority
- CN
- China
- Prior art keywords
- chromene
- phosphorus
- thiophosphine
- ester
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 150000002148 esters Chemical class 0.000 title claims abstract description 10
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 title description 4
- 239000002253 acid Substances 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011574 phosphorus Substances 0.000 claims abstract description 11
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 6
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- -1 phospho Chemical class 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 239000010410 layer Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000012044 organic layer Substances 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 239000002024 ethyl acetate extract Substances 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 230000005693 optoelectronics Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- PKUWKAXTAVNIJR-UHFFFAOYSA-M O,O-diethyl thiophosphate Chemical compound CCOP([O-])(=S)OCC PKUWKAXTAVNIJR-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 150000003017 phosphorus Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 229940122041 Cholinesterase inhibitor Drugs 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
本发明公开了一种4‑(2H‑色烯)‑硫代膦(磷)酸酯的制备方法,所述的方法是以邻炔丙醇苯酚为原料,于室温条件下加入有机溶剂充分溶解,而后加入含P(O)‑SH类化合物,在80℃下反应,反应结束后,反应产物经硅胶柱层析分离纯化得到如目标物。本发明具有原料简单易得、反应条件温和、操作简便、底物扩展性好、产率高等特点;制备得到的目标产物4‑(2H‑色烯)‑硫代膦(磷)酸酯可以应用于有机合成、医学、光电材料等邻域,是一种具有较好推广应用前景的化学合成方法。
Description
技术领域
本发明属于有机合成技术领域,具体涉及一种4-(2H-色烯)-硫代膦(磷)酸酯的制备方法。
背景技术
含有P-S-C(SP2)键结构的硫代磷酸酯类化合物,在药物方面可以作为医药中间体、杀虫剂、杀菌剂、固化促进剂、抗静电剂及一种胆碱酯酶抑制剂。在功能材料方面,作为表面活性剂、光电材料、含磷阻燃剂。同样,硫代磷酸酯类化合物作为合成中间体在有机合成领域具有重要作用。
此外,2H-色烯骨架化合物是一类非常重要的化合物,具有一定的药理性质,是目前合成很多天然化合物和药物活性分子的重要中间体,同时也有一定的保健作用。因此,对2H-色烯骨架化合物的合成具有非常重要的应用前景和理论指导,受到有机合成家的关注。虽然目前构建4-位官能团化2H-色烯衍生物的方法有很多,但是对于构建4-(2H-色烯)-硫代膦(磷)酸酯的文献到目前为止仍未见报道。
发明内容
本发明的目的就是提供一种原料易得、反应条件温和、应用前景好的4-(2H-色烯)-硫代膦(磷)酸酯的制备方法。
本发明的一种4-(2H-色烯)-硫代膦(磷)酸酯的制备方法,是以邻炔丙醇苯酚()为原料,于室温条件下加入有机溶剂充分溶解,而后加入含P(O)-SH类化合物,在80℃下反应4-6小时,反应结束后,反应产物经硅胶柱层析分离纯化得到如式()所示的4-(2H-色烯)-硫代膦(磷)酸酯;
()、 (),
其中式()或式()中的R1~R4各自独立为H、CH3、X(F、Cl、Br)、OCH3中的任意一种;R5与R6均为不同取代基取代的芳基;R为各自独立的烷氧基或芳氧基。
所述反应的反应式如下:
,
其中,所述的有机溶剂的质量为邻炔丙醇苯酚化合物质量的10-30倍,所述的有机溶剂为乙腈或硝基甲烷。
本发明中,推荐所述的邻炔丙醇苯酚、含P(O)-SH类化合物的物质的量之比为1:1.5~2.5,优选1:2.0。
本发明反应过程中以TCL跟踪反应进度时间,推荐所述反应时间为4-6小时,优选4小时。
本发明中控制所述方法的反应温度为80℃。
本发明中所述的方法按照如下步骤进行:将邻炔丙醇苯酚()在室温条件下溶于有机溶剂中,而后加含P(O)-SH类化合物,在80℃下反应4~6小时,反应结束后,反应产物分离纯化得到4-(2H-色烯)-硫代膦(磷)酸酯。
本发明中所述的分离纯化可采用如下步骤:将反应液加入饱和碳酸氢酸钠溶液,再加入乙酸乙酯,充分搅拌后静置分层;分出的水层用乙酸乙酯萃取,将乙酸乙酯的萃取物与分出的有机层合并后分别用饱和食盐水洗涤、无水硫酸钠干燥;蒸除乙酸乙酯溶剂,其后经硅胶柱层析分离纯化得到4-(2H-色烯)-硫代膦(磷)酸酯。
本发明与现有技术相比,其有益效果体现在:1、提供一种新的合成策略;2、本发明的反应无需催化剂,条件温和;3、本发明方法操作简便、简单易得,底物适用性也广,得到不同取代基4-(2H-色烯)-硫代膦(磷)酸酯。
具体实施方式
实施例1: (2,2-二苯基-2H-色烯-4-基)-硫代磷酸二乙酯的制备
,
代表性的实施过程:室温下,依次向反应瓶中加入邻炔丙醇苯酚-1 (150 mg, 0.5mmol)和3 ml 干燥硝基甲烷,然后将硫代磷酸二乙酯(170 mg, 1 mmol)加入到反应瓶中,随后将反应置于80℃下反应4小时。TLC跟踪反应进度,反应结束后,将反应液加入饱和碳酸氢钠溶液,再加入乙酸乙酯,充分搅拌后静置分层;分出的水层用乙酸乙酯萃取,将乙酸乙酯的萃取物与分出的有机层合并后分别用饱和食盐水洗涤、无水硫酸钠干燥;蒸除乙酸乙酯溶剂,其后经硅胶柱层析分离纯化得到(2,2-二苯基-2H-色烯-4-基)-硫代磷酸二乙酯178mg, 反应收率79%。
淡黄色液体,1H NMR (400 MHz, CDCl3): δ ppm 1.20 (t, J = 7.2 Hz, 6 H),4.04 – 4.23 (m, 4 H), 6.74 (d, J = 4.4 Hz, 1 H), 6.89 – 6.95 (m, 2 H), 7.15 –7.19 (m, 1 H), 7.24 – 7.30 (m, 2 H), 7.31 – 7.34 (m, 4 H), 7.43 – 7.45 (m, 4H), 7.59 (d, J = 7.6 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ ppm 15.8, 15.9,64.3, 64.3, 83.6, 116.8, 121.3, 121.5, 121.5, 121.5, 121.6, 125.5, 127.0,127.8, 128.2, 130.6, 137.7, 137.8, 143.8, 143.8, 152.6. 31P NMR (162 MHz,CDCl3): δ 22.32. HRMS (ESI, m/z): calcd for C25H25O4PS: M+H = 453.1284; found:453.1286。
实施例2: (2,2-二对甲基苯基-2H-色烯-4-基)-硫磷酸二乙酯的制备
,
室温下,依次向反应瓶中加入邻炔丙醇苯酚-2 (164 mg, 0.5 mmol)和ml 干燥硝基甲烷,然后将硫代磷酸二乙酯(170 mg, 1 mmol)加入到反应瓶中, 随后将反应置于80℃下反应4小时, TLC跟踪反应进度。分离纯化步骤同实施例1,得到(2,2-二对甲基苯基-2H-色烯-4-基)-硫磷酸二乙酯148.8 mg, 反应收率62%。
淡黄色液体,1H NMR (400 MHz, CDCl3): δ ppm 1.20 (t, J = 7.2 Hz, 6 H),2.31 (s, 6 H), 4.06 – 4.14 (m, 2 H), 4.15 – 4.22 (m, 2 H), 6.70 (d, J = 4.4Hz, 1 H), 6.88 – 6.93 (m, 2 H), 7.10 – 7.18 (m, 5 H), 7.30 – 7.32 (m, 4 H),7.57 (d, J = 7.6 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ ppm 15.9, 16.0, 21.1,64.4, 64.4, 83.5, 116.9, 121.1, 121.2, 121.5, 121.5, 125.6, 127.0, 128.9,130.5, 137.5, 138.3, 138.4, 141.0, 152.8. 31P NMR (162 MHz, CDCl3): δ 22.53.HRMS (ESI, m/z): calcd for C27H29O4PS: M+H = 481.1597; found: 481.1603。
实施例3: (2-对氟苯基-2-对甲氧基苯基-2H-色烯-4-基)-硫代磷酸二乙酯的制备
,
室温下,依次向反应瓶中加入邻炔丙醇苯酚-3 (174 mg, 0.5 mmol)和ml 干燥硝基甲烷,然后将硫代磷酸二乙酯(170 mg, 1 mmol)加入到反应瓶中, 随后将反应置于80℃下反应4小时, TLC跟踪反应进度。分离纯化步骤同实施例1,得到(2-对氟苯基-2-对甲氧基苯基-2H-色烯-4-基)-硫代磷酸二乙酯197.5mg, 反应收率79%。
淡黄色固体,mp: 91–93 ºC. 1H NMR (400 MHz, CDCl3): δ ppm 1.22 (t, J =7.2 Hz, 6 H), 3.77 (s, 3 H), 4.07 – 4.14 (m, 2 H), 4.16 – 4.23 (m, 2 H), 6.67(d, J = 4.4 Hz, 1 H), 6.84 (d, J = 8.8 Hz, 2 H), 6.90 – 6.94 (m, 2 H), 7.00(t, J = 8.4 Hz, 2 H), 7.15 – 7.18 (m, 1 H), 7.33 (d, J = 8.8 Hz, 2 H), 7.40 –7.44 (m, 2 H), 7.58 – 7.60 (m, 1 H). 13C NMR (100 MHz, CDCl 3): δ ppm 15.9, 16.0,55.3, 64.4, 64.5, 83.0, 83.0, 113.6, 114.9, 115.2, 116.9, 121.5, 121.5,121.5, 121.6, 121.6, 125.6, 128.4, 128.9, 129.0, 130.7, 135.8, 137.8, 137.9,139.9, 152.5, 159.2, 161.0, 163.4. 31P NMR (162 MHz, CDCl3): δ 22.48. HRMS(ESI, m/z): calcd for C26H26FO5PS: M+H = 501.1295; found: 501.1298。
实施例4: (2-苯基-2-对甲基苯基-2H-色烯-4-基)-硫代磷酸二乙酯的制备
,
室温下,依次向反应瓶中加入邻炔丙醇苯酚-4 (157 mg, 0.5 mmol)和ml 干燥硝基甲烷,然后将硫代磷酸二乙酯(170 mg, 1 mmol)加入到反应瓶中, 随后将反应置于80℃下反应4小时, TLC跟踪反应进度。分离纯化步骤同实施例1,得到(2-苯基-2-对甲基苯基-2H-色烯-4-基)-硫代磷酸二乙酯191mg, 反应收率82%。
淡黄色固体, mp: 72–74 ºC. 1H NMR (400 MHz, CDCl3): δ ppm 1.20 (t, J =7.2 Hz, 6 H), 2.31 (s, 3 H), 4.04 – 4.24 (m, 4 H), 6.72 (d, J = 4.4 Hz, 1 H),6.88 – 6.94 (m, 2 H), 7.11 – 7.19 (m, 3 H), 7.23 – 7.27 (m, 1 H), 7.29 – 7.33(m, 4 H), 7.43 – 7.45 (m, 2 H), 7.58 (dd, J = 1.2, 7.6 Hz, 1 H). 13C NMR (100MHz, CDCl3): δ ppm 15.9, 16.0, 21.1, 64.3, 64.4, 83.5, 83.6, 116.9, 121.3,125.6, 127.0, 127.1, 127.7, 128.2, 128.9, 130.6, 137.6, 138.0, 138.1, 140.9,144.0, 152.7. 31P NMR (162 MHz, CDCl3): δ 22.38. HRMS (ESI, m/z): calcd forC26H27O4PS: M+H = 467.1440; found: 467.1444。
Claims (4)
1.一种4-(2H-色烯)-硫代膦(磷)酸酯的制备方法,其特征在于:所述的方法是以邻炔丙醇苯酚()为原料,于室温条件下加入有机溶剂充分溶解,而后加入含P(O)-SH类化合物,在80℃下反应4-6小时,反应结束后,反应产物经硅胶柱层析分离纯化得到如式()所示的4-(2H-色烯)-硫代膦(磷)酸酯;
(), (),
其中式()或式()中的R1~R4各自独立为H、CH3、X(F、Cl、Br)、OCH3中的任意一种;R5与R6均为不同取代基取代的芳基;R为各自独立的烷氧基或芳氧基。
2.如权利要求1所述的4-(2H-色烯)-硫代膦(磷)酸酯的制备方法,其特征在于:所述原料投料物质的量比,邻炔丙醇苯酚:含P(O)-SH类化合物为1:1.5~2.5。
3.如权利要求1所述的4-(2H-色烯)-硫代膦(磷)酸酯的制备方法,其特征在于:所述的有机溶剂为乙腈、硝基甲烷中的一种。
4.如权利要求1所述的4-(2H-色烯)-硫代膦(磷)酸酯的制备方法,其特征在于:所述分离纯化的方法为,将反应液加入饱和碳酸氢酸钠溶液,再加入乙酸乙酯,充分搅拌后静置分层;分出的水层用乙酸乙酯萃取,将乙酸乙酯的萃取物与分出的有机层合并后分别用饱和食盐水洗涤、无水硫酸钠干燥;蒸除乙酸乙酯溶剂,其后经硅胶柱层析分离纯化得到4-(2H-色烯)-硫代膦(磷)酸酯。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910762744.XA CN110526940A (zh) | 2019-08-19 | 2019-08-19 | 一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910762744.XA CN110526940A (zh) | 2019-08-19 | 2019-08-19 | 一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110526940A true CN110526940A (zh) | 2019-12-03 |
Family
ID=68663641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910762744.XA Pending CN110526940A (zh) | 2019-08-19 | 2019-08-19 | 一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110526940A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232501A (zh) * | 2018-10-10 | 2019-01-18 | 江西科技师范大学 | 一种4-对甲苯磺酸酯-2h-色烯的制备方法 |
CN109824725A (zh) * | 2019-03-11 | 2019-05-31 | 江西科技师范大学 | 一种4-磷酸酯-2h-色烯衍生物的制备方法 |
-
2019
- 2019-08-19 CN CN201910762744.XA patent/CN110526940A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232501A (zh) * | 2018-10-10 | 2019-01-18 | 江西科技师范大学 | 一种4-对甲苯磺酸酯-2h-色烯的制备方法 |
CN109824725A (zh) * | 2019-03-11 | 2019-05-31 | 江西科技师范大学 | 一种4-磷酸酯-2h-色烯衍生物的制备方法 |
Non-Patent Citations (1)
Title |
---|
QIU, YI-FENG ET AL.: "BF3·OEt2-AgSCF3 Mediated Trifluoromethylthiolation/Cascade Cyclization of Propynols: Synthesis of 4-((Trifluoromethyl)thio)-2H-chromene and 4-((Trifluoromethyl)thio)-1,2-dihydroquinoline Derivatives", 《ORGANIC LETTERS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reddy et al. | PEG-SO3H catalyzed synthesis and cytotoxicity of α-aminophosphonates | |
CN102336783B (zh) | 一种异构反应 | |
CN109265475B (zh) | 一种多取代芳基乙烯硼酸频哪醇酯衍生物的制备方法 | |
Yuan et al. | Silver-catalyzed synthesis of 2-arylvinylphosphonates by cross-coupling of β-nitrostyrenes with H-phosphites | |
CN109824725B (zh) | 一种4-磷酸酯-2h-色烯衍生物的制备方法 | |
CN108456227B (zh) | 一种1,1-二氟-3-磺酰基-2-氯-3-丁烯基膦酸酯化合物及其合成方法和应用 | |
CN105566384A (zh) | 一种(E)-2-芳基-α,β-不饱和羰基膦酸酯衍生物的制备方法 | |
JPH01275581A (ja) | 抗腫瘍性物質sf2582誘導体 | |
CN110526940A (zh) | 一种4-(2h-色烯)-硫代膦(磷)酸酯的制备方法 | |
CN105153030A (zh) | 全氟基团取代的异喹啉-1,3(2h,4h)-二酮及其制法和用途 | |
CN108689892B (zh) | 3-磺酰化-二氢茚酮类化合物及其制备方法 | |
CN108329347A (zh) | 一种制备β-氯代烯基膦酰类衍生物的方法 | |
CN105037428B (zh) | 一种香豆素‑3‑膦酸酯衍生物的制备方法 | |
CN108129512B (zh) | 一种烯丙基硫代或硒代磷酸酯和膦酸酯的制备方法 | |
CN110804069B (zh) | 一种硫代膦(磷)酸酯取代的联烯化合物制备方法 | |
CN115785148B (zh) | 一种硫代膦(磷)酸酯取代苯并芴化合物的制备方法 | |
CN108383872A (zh) | 一种-1,1-二氟-3-磺酰基-2,4-戊二烯膦酸酯类化合物及其合成方法和应用 | |
CN103896927A (zh) | (r)/(s)-1-(2,3-环氧丙基)-n-硝基亚咪唑烷-2-亚胺的制备方法 | |
CN108530515A (zh) | 天然产物be-43547环状母核的制备方法 | |
CN105968059A (zh) | N-烯基苯并三唑类氮氧衍生物及其制备方法和应用 | |
ES2211919T3 (es) | Metodo para preparar esteres de acidos halonicotinicos. | |
CN105622544B (zh) | 一种n-磺酰基-3,4-二氢-2h-1,4-噻嗪的合成方法 | |
CN105399683B (zh) | 苯并咪唑衍生物及其制备方法 | |
CN112010882A (zh) | 立体选择性制备1,3-双取代环己烷类化合物的方法及应用 | |
CN114989214B (zh) | 一种紫草素氨基磷酸酯杂合体及其合成方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191203 |
|
RJ01 | Rejection of invention patent application after publication |